App-Quantinova.ai

Serum hepcidin levels predict intestinal iron absorption in IBD patients

A. Dignass - European Crohn’s and Colitis Organisation (ECCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Diagnosis of iron deficiency in inflammatory bowel diseases by transferrin receptor-ferritin index

A. Esch - European Crohn’s and Colitis Organisation (ECCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

The type of iron deficiency anaemia, but not the underlying disease, predicts intestinal iron absorption in IBD patients

A. Dignass - European Crohn’s and Colitis Organisation (ECCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

Ferrous sulfate

Hypogonadal patients with Crohn's disease benefit from treatment with testosterone - data from an ongoing, long-term, observational registry study

M. Nasser - European Crohn’s and Colitis Organisation (ECCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

LPCN 1111

Factors associated with the development of extraintestinal manifestations in patients with ulcerative colitis

G. Sanchez-Morales - European Crohn’s and Colitis Organisation (ECCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

N/A

Circulating microRNA223 is a new biomarker for inflammatory bowel disease

S. Zhang - European Crohn’s and Colitis Organisation (ECCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

N/A

A Study of Relation Between Adipocytokines, Adipocity, HOMA-R and HRV Parameters of Autonomic Function in Asian Indian Diabetics

Sandeep Kumar Mathur - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Pioglitazone

Selenoprotein-P Is Predictive of Insulin Resistance and Systemic Inflammation in Individuals with Prediabetes and Diabetes

Manoj Kumar - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Systemic inflammation

Interleukin

Hypogonadal Patients with Crohn's disease Benefit from Treatment with Testosterone Further Data from an Ongoing, Long-Term, Observational Registry Study

Farid Saad - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Crohn's disease

LPCN 1111

The Role of Visceral Adiposity Index and TG/HDL-C Levels in Predicting Endothelial Dysfunction, Inflammation and Insulin Resistance in Hypogonadism

Cem Haymana - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

N/A

Cardiovascular Risk in Patients with Autoimmune Thyroiditis and Normal-High Levels of TSH

Celestino Neves - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune Thyroid Disease

Cyanocobalamin

Insulin Resistance, Lipoprotein Profile, Homocysteine, Folate, Vitamin B12, High-Sensitivity C-Reactive Protein and Insulin Resistance in Grave- Disease

Celestino Neves - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congenital hyperthyroidism

Cyanocobalamin

Waist Height Ratio As a Marker of Obesity and Insulin Resistance in Adolescents

V. Sri Nagesh - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Tuberculosis

N/A

Leptin Is Independently Associated with Depressive Symptoms in Older Adults with Obesity

Amy Miskimon Goss - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Depression

N/A

Acute and long-term effect of PCI on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina

Leibundgut G - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

An increased concentration of matrix metalloproteinase-9 in the blood after coronary stenting lasts much longer than the increase of other markers of inflammation

Provatorov S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Restenosis

Fibrinogen (IV)

The red cell distribution width demonstrated a significant impact on the incidence of vasospastic angina in Korean patients: results from the multicentre registry

Shin D.I - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

ergonovine

The prognostic value of high-sensitive C-Reactive protein in patients with coronary artery ectasia

Wang Y.T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary artery ectasia

N/A

CARDIOVASCULAR RISK AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH GOUT: EXPERIENCE IN A MULTIHOSPITAL SPANISH GROUP

E. Calvo Aranda - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Left ventricular hypertrophy

Angiotensin II

FACTORS ASSOCIATED WITH PRECLINICAL ATHEROSCLEROTIC CHANGES IN CAROTID ARTERY IN MEN WITH GOUT

H. Tag - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Arterial stiffness

N/A

Filters

1408 Abstracts